VivoSim Labs, Inc. (VIVS)
NASDAQ: VIVS · Real-Time Price · USD
3.640
-0.200 (-5.21%)
At close: Sep 17, 2025, 4:00 PM EDT
3.660
+0.020 (0.55%)
After-hours: Sep 17, 2025, 7:58 PM EDT
VivoSim Labs Market Cap
VivoSim Labs has a market cap or net worth of $9.46 million as of September 17, 2025. Its market cap has increased by 2.86% in one year.
Market Cap
9.46M
Enterprise Value
1.23M
1-Year Change
2.86%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since February 14, 2012, VivoSim Labs's market cap has decreased from $11.20M to $9.46M, a decrease of -15.51%. That is a compound annual growth rate of -1.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 10.00M | 40.85% |
| Dec 31, 2024 | 7.10M | -27.55% |
| Dec 29, 2023 | 9.80M | -20.33% |
| Dec 30, 2022 | 12.30M | -61.08% |
| Dec 31, 2021 | 31.60M | -61.84% |
| Dec 31, 2020 | 82.80M | 78.45% |
| Dec 31, 2019 | 46.40M | -58.16% |
| Dec 31, 2018 | 110.90M | -22.61% |
| Dec 29, 2017 | 143.30M | -59.30% |
| Dec 30, 2016 | 352.10M | 53.02% |
| Dec 31, 2015 | 230.10M | -60.58% |
| Dec 31, 2014 | 583.70M | -31.77% |
| Dec 31, 2013 | 855.50M | 600.66% |
| Dec 31, 2012 | 122.10M | 990.18% |
| Feb 14, 2012 | 11.20M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.36B |
| Johnson & Johnson | 428.37B |
| AbbVie | 380.71B |
| UnitedHealth Group | 316.84B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.52B |